Transcription factor AP-2 Beta, a potential target of repetitive Transspinal magnetic stimulation in spinal cord injury treatment, reduced inflammation and alleviated spinal cord injury

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 903c72ea0ede26b0-LAX IP: 116.62.10.13 UTC time: 2025-01-18T06:15:09+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4